Drug
CKD-383 clinical trials
Also written CKD-383.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How studies write it
Studies that test it under each name
Development codes
- CKD-383
- 5
Studies by the year they started
5 studies that test it; most in 2023 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses CKD-383 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy VolunteersCompletedPhase 1Chong Kun Dang PharmaceuticalNCT06695572Written as CKD-383
- Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy VolunteersCompletedPhase 1Chong Kun Dang PharmaceuticalNCT06695598Written as CKD-383
- Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029CompletedPhase 1Chong Kun Dang PharmaceuticalNCT05897216Written as CKD-383
- Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150CompletedPhase 1Chong Kun Dang PharmaceuticalNCT05816759Written as CKD-383
- A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.CompletedPhase 1Chong Kun Dang PharmaceuticalNCT04810676Written as CKD-383